ScreenerHero vs Koyfin

Koyfin is a research terminal with a screener attached. ScreenerHero is a screener with charts attached. No subscription.

Koyfin Plus is a well-regarded platform at $39/month — professional dashboards, macro data, and global charting. The screener is capable but secondary to the research workflow Koyfin is built around. ScreenerHero inverts the hierarchy: the screener is the product. If you spend most of your time filtering stocks rather than building dashboards, ScreenerHero has a one-time paid plan and covers the European microcap universe Koyfin misses.

Koyfin Plus

$39/mo

vs

ScreenerHero Lifetime

97€ once · no subscription

Updated October 2026 · Honest comparison, including where Koyfin is genuinely better

After about 3 months, Koyfin Plus has cost you more than ScreenerHero Lifetime (97€, once).

Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.

Which is better, ScreenerHero or Koyfin?

It depends on whether you screen or analyse. Koyfin is a research terminal: custom dashboards, macro data, multi-asset charts and portfolio analytics. ScreenerHero is a screener first, with candlestick charts and a portfolio tracker, and it covers European microcaps where Koyfin's data is thinner. If you live in dashboards and macro, choose Koyfin. If you mostly filter stocks and prefer a one-time payment to a monthly fee, choose ScreenerHero.

The core difference

Koyfin: a professional research terminal

Koyfin is built for investors who want a Bloomberg-lite experience — custom dashboards, multi-asset charts, macro data, portfolio tracking, and peer comparisons. The screener is solid and covers global markets, but it is one feature among many. The $39/month Plus plan includes a lot of capability that screener-focused investors may never touch.

ScreenerHero: a screener, nothing else

ScreenerHero is built around one workflow: filter thousands of stocks by fundamental criteria and surface actionable ideas. The charts are functional rather than the focus. There are no macro dashboards and no economic indicator overlays, and the portfolio tracker is simpler than a full analytics suite. Every product decision prioritises screening speed and European fundamental coverage over research features. With a one-time paid plan, you are paying for exactly what you use.

Where Koyfin is genuinely better

Professional dashboards

Koyfin's custom dashboard builder — with drag-and-drop widgets, multi-asset charting, and saved layouts — is significantly more powerful than anything in ScreenerHero. Analysts and portfolio managers who live in a terminal will find Koyfin closer to the Bloomberg/FactSet experience at a fraction of the price.

Macro and economic data

GDP, CPI, yield curves, central bank rates, PMI — all integrated alongside equity data. ScreenerHero is equity-only. If your investment thesis starts with macro and flows down to stock selection, Koyfin is the better tool.

Portfolio tracking and peer analysis

Multi-portfolio monitoring, custom metric tracking, and peer comparison groups are well-developed in Koyfin Plus. ScreenerHero has watchlists, a portfolio tracker and a stock comparison tool, but Koyfin's multi-portfolio monitoring, custom metrics and peer groups go further.

Charting quality

Koyfin's charting is substantially more capable — multi-asset overlays, custom time periods, technical indicators, and comparison charts. ScreenerHero's charts (candlesticks, 15+ indicators, drawing tools) serve the screener workflow, not deep multi-asset chart analysis.

Historical financial data depth

Koyfin Plus includes 10Y+ historical financials for most global companies. ScreenerHero focuses on current-period fundamentals for screening, not historical trend analysis.

Where ScreenerHero is genuinely better

European microcap coverage

Euronext Growth Paris, Nasdaq First North, EGM Milan, GPW NewConnect — alternative market listings across Europe where data coverage is thinnest. ScreenerHero covers these markets as a core priority. Koyfin's fundamental data for sub-€300M European listings is inconsistent.

No monthly fee for screener-focused users

Koyfin Plus is $39/month, every month. If you use the screener 80% of the time and ignore dashboards, you are paying a recurring subscription for features you are not using. The ScreenerHero paid plan is a one-time Lifetime payment, a better fit for screener-centric workflows.

No account required

ScreenerHero's full screener works without creating an account. Koyfin requires account creation before accessing anything. Useful for evaluators or one-off searches.

Screening as the primary UX

In ScreenerHero, the screener is always one click away. In Koyfin, it is nested within a broader research interface. For investors who filter stocks as their primary daily action, the ScreenerHero UX is more direct.

Transparent data gaps

When fundamental data is unavailable for a European microcap, ScreenerHero shows the gap explicitly rather than filling it with stale or estimated values.

Side-by-side comparison

FeatureScreenerHeroKoyfin Plus
Primary use case
Strong: Screening-first — filter, rank, and surface ideas systematically
Partial: Dashboard and charting-first — monitor, analyse, and research
European stock coverage
Strong: All major European exchanges including microcaps on alternative markets
Partial: Global coverage — European large and mid caps well covered, microcap gaps
European microcap fundamentals
Strong: Reliable P/E, ROE, EV/EBITDA for EU small caps including alternative markets
Weak or absent: Inconsistent below ~€300M — alternative market coverage limited
US stock coverage
Strong: Full — NYSE, NASDAQ, NYSE American
Strong: Comprehensive — major US exchanges and OTC
Canadian stock coverage
Strong: TSX and TSXV
Partial: Partial — major TSX names, limited TSXV coverage
Charting and dashboards
Partial: Candlestick charts with 15+ indicators and drawing tools — functional, not the focus
Strong: Professional-grade — multi-asset charts, custom dashboards, macro overlays
Macro and economic data
Weak or absent: Not available
Strong: GDP, inflation, yield curves, central bank rates — well integrated
Screener depth
Strong: Fundamental-first — P/E, P/B, ROE, EV/EBITDA, margins, dividend yield, beta
Partial: Screener available but secondary to the dashboard/research workflow
Watchlist and portfolio tracking
Partial: Watchlists, a portfolio tracker (trades, P&L, allocation, risk) and a stock comparison tool
Strong: Advanced — multi-portfolio tracking, custom metrics, peer comparison
Free tier
Strong: Full screener free — no account required
Partial: Limited free tier — 2 saved screens, 2Y historical data, Koyfin branding
Price (paid plan)
Strong: Free screener, no account needed · Lifetime: 97€ once, no subscription
Weak or absent: $39/mo Plus (≈€36/mo) · $79/mo Pro (≈€72/mo) — significantly more expensive
No account required
Strong: Yes — full screener works without login
Weak or absent: No — account required for any feature access
LegendStrongPartial / neutralAbsent / weak

Seen enough? Try it on your own criteria.

Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.

Which to use — by workflow

If

Screening is your primary workflow — you filter thousands of stocks by criteria to surface ideas

ScreenerHero — built specifically for this. Koyfin's screener is capable but secondary to its dashboard and research tools.

If

You want professional-grade multi-asset charts with macro overlays and custom dashboards

Koyfin — the dashboard and charting quality is significantly ahead of ScreenerHero's charts.

If

You need to track macroeconomic indicators alongside equity data

Koyfin — GDP, inflation, yield curves, and central bank data integrated with stock analysis is a Koyfin strength ScreenerHero lacks.

If

You screen European microcaps on Euronext Growth, First North, or EGM

ScreenerHero — Koyfin's fundamental data for these markets is inconsistent. ScreenerHero covers them as a primary focus.

If

You want the cheapest path to global fundamental screening

ScreenerHero — Koyfin Plus is $39/mo for a more complex tool. If you use 80% of your time in the screener, you're paying every month for features you don't use.

If

You manage multiple portfolios and want peer comparisons and custom metric tracking

Koyfin Plus — the portfolio tools and peer analysis are significantly more advanced than ScreenerHero's current feature set.

If

You want to start screening without creating an account

ScreenerHero — Koyfin requires account creation before accessing any feature.

Can you use both?

Yes — they serve different parts of the research workflow. Use ScreenerHero to filter and surface stock ideas from the full US, Canadian, European & Australian universe. Then open Koyfin to build a dashboard, chart the business over time, and compare it against peers. The tools are complementary rather than competing for the same workflow step. ScreenerHero is free to start — no account needed.

If screening is your primary workflow, stop paying for dashboard features you don't use.

P/E, ROE, EV/EBITDA, margins, dividend yield — US, Canadian, European & Australian stocks including microcaps. Dense. Fast. Free to start, no account needed. Lifetime access is a one-time 97€ payment — no subscription.

Free screener: no signup, no credit card. Lifetime: no subscription, 30-day money-back guarantee.

Other comparisons →